Gamma-Hydroxybutyrate Reduces both Withdrawal Syndrome and Hypercortisolism in Severe Abstinent Alcoholics: An Open Study vs. Diazepam

REFERENCES

• Yost DA. Alcohol withdrawal syndrome. Am Fam Physician 1996; 54:657–664.
   PubMed Web of Science ®Google Scholar
• Hall W, Zador D. The alcohol withdrawal syndrome. The Lancet 1997; 349:1897–1900.
   PubMed Web of Science ®Google Scholar
• Mayo-Smith MF. For the American Society of Addiction Medicine working group for practice guideline on pharmacological management of alcohol withdrawal. Pharmacological management of alcohol withdrawal: A meta-analysis and evidence-based practice guideline. JAMA 1997; 278:144–151.
   PubMed Web of Science ®Google Scholar
• Saitz R, O'Malley SS. Pharmacotherapies for alcohol abuse, withdrawal and treatment. Med Clin North Am 1997; 81:881–907.
   PubMed Web of Science ®Google Scholar
• O'Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med 1998; 338:592–602.
   PubMed Web of Science ®Google Scholar
• Williams D, McBride AJ. The drug treatment of alcohol withdrawal symptoms: A systematic review. Alcohol Alcohol 1998; 33:103–115.
   PubMed Web of Science ®Google Scholar
• Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence. A review of the evidence. JAMA 1999; 281:1318–1325.
   PubMed Web of Science ®Google Scholar
• Myrick H, Brady KT, Malcolm R. New developments in the pharmacotherapy of alcohol dependence. Am J Addict 2001; 10S:3–15.
   Google Scholar
• Mayo-Smith MF, Beecher LH, Fisher TL, Gorelick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J. Working Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction Medicine. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 2004; 164:1405–1412.
   PubMed Web of Science ®Google Scholar
• Shaw GK. Detoxification: the use of benzodiazepines. Alcohol Alcohol 1995; 30:65–770.
   Web of Science ®Google Scholar
• Lejoyeux M, Solomon J, Ades J. Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol 1998; 103–115.
   PubMed Web of Science ®Google Scholar
• Holbrook A, Crowterth R, Lotter A, Cheng C, King D. Meta-analysis of acute alcohol withdrawal. CMAJ 1999; 160:649–655.
   PubMed Web of Science ®Google Scholar
• Ntais C, Pakos E, Kyzas P, Ionnidis JP. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2005; (3):CD005063.
   PubMed Web of Science ®Google Scholar
• Horwitz RI, Gottlieb LD, Kraus ML. The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome: Results of a randomized clinical trial. Arch Intern Med 1989; 149:1089–1093.
   PubMedGoogle Scholar
• Robinson BJ, Robinson GM, Maling TJ, Johnson RH. Is clonidine useful in the treatment of alcohol withdrawal? Alcohol Clin Exp Res 1989; 4:400–405.
   Google Scholar
• Worner TM. Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: Double-blind controlled trial. Am J Drug Alcohol Abuse 1994; 20:115–124.
   PubMed Web of Science ®Google Scholar
• Ritola E, Malinen L. A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatrica Scandinavica 1981; 64:254–259.
   PubMed Web of Science ®Google Scholar
• Malcolm R, Ballenger JC, Sturgis ET, Ballenger JC. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989; 146:617–621.
   PubMed Web of Science ®Google Scholar
• Stuppaeck CH, Pycha R, Miller C, Whitworth AB, Oberbauer H, Fleischhacker WW. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal. Alcohol Alcohol 1992; 27:153–158.
   PubMed Web of Science ®Google Scholar
• Pages KP, Ries RK. Use of anticonvulsants in benzodiazepine withdrawal. Am J Addict 1998; 7:198–204.
   PubMed Web of Science ®Google Scholar
• Bonnet U, Bonger M, Leweke FM, Maschke M, Kowalski T, Gastpar M. Treatment of alcohol withdrawal syndrome with gabapentin. Pharmacopsychiatry 1999; 32:107–109.
   PubMed Web of Science ®Google Scholar
• Malcolm R, Myrick H, Brady KT, Baer JS, Shoan KL. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 2001; 10:16–23.
   PubMed Web of Science ®Google Scholar
• Reoux JP, Saxon AJ, Malte CA, Baer JS, Shoan KL. Dilvaproex sodium in alcohol withdrawal: A randomized double-blind placebo-controlled clinical trial. Alcohol Clin Exp Res 2001; 25:1324–1329.
   PubMed Web of Science ®Google Scholar
• Book SW, Myrick H. Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs 2005; 14:371–376.
   PubMed Web of Science ®Google Scholar
• Polycarpou A, Papanikolaou P, Ioannidis JP, Contopoulos-Ioannidis DG. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 2005; (3):CD005064.
   PubMedGoogle Scholar
• Murphy DJ, Shaw GK, Clarke I. Tiapride and chlormethiazole in alcohol withdrawal: A double-blind trial. Alcohol Alcohol 1981; 18:227–237.
   Web of Science ®Google Scholar
• Borg V, Weinholt T. Bromocriptine in the treatment of alcohol withdrawal syndrome. Acta Psychiatrica Scandinavica 1982; 65:101–111.
   PubMed Web of Science ®Google Scholar
• Burroughs AK, Morgan MY, Sherlock S. Double blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms. Alcohol Alcohol 1985; 20:263–271.
   PubMed Web of Science ®Google Scholar
• Franz M, Dlabal H, Kunz S, Ulferts J, Gruppe H, Gallhofer B. Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study. Eur Arch Psychiatry Clin Neurosci 2001; 251:185–192.
   PubMed Web of Science ®Google Scholar
• Frave JD, Allain H, Aubin HJ, Frija-Orvoen E, Gillet C, Lejoyeux M, Payen A, Weber M, Garcia-Acosta S, Kermadi I, Dib M. Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome. Hum Psychopharmacol 2005; 20:511–519.
   PubMed Web of Science ®Google Scholar
• Sellers EM, Cooper SD, Zilm DH, Shanks C. Lithium treatment during alcohol withdrawal. Clin Pharmacol Ther 1976; 20:199–206.
   PubMed Web of Science ®Google Scholar
• Lapierre YD, Bulmer DR, Oyewumi LK, Mauguin ML, Knott VJ. Comparison of chloromethiazole (Heminevrin) and chlorodiazepoxide (Librium) in the treatment of acute alcohol withdrawal. Neuropsychobiology 1983; 10:127–130.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G. Baclofen in the treatment of alcohol withdrawal syndrome: A comparative study vs diazepam. Am J Med 2006; 119:13–18.
   Web of Science ®Google Scholar
• Okun MS, Boothby LA, Bartfield RB, Doering PL. GHB: An important pharmacological and clinical update. J Pharm Pharmaceut Sci 2001; 4:167–175.
   PubMed Web of Science ®Google Scholar
• Wong CGT, Gibson KM, Snead III OC. From the street to the brain: Neurobiology of the recreational drug γ-hydroxybutyric acid. Trends Pharmacol Sci 2004; 25:29–34.
   PubMed Web of Science ®Google Scholar
• Laborit H. Sodium 4-hydroxybutyrate. Int J Neuropsychopharmacol 1964; 3:433–452.
   Google Scholar
• Mamelak M, Scharf M, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate: A review of clinical and sleep laboratory findings. Sleep 1986; 9:285–289.
   PubMed Web of Science ®Google Scholar
• Borgen LA, Okerholm RA, Lai A, Scharf MB. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 2004; 44:253–257.
   PubMed Web of Science ®Google Scholar
• Poldrugo F, Addolorato G. The role of γ-hydroxybutyric acid in the treatment of alcoholism: From animal to clinical studies. Alcohol Alcohol 1999; 34:15–24.
   PubMed Web of Science ®Google Scholar
• Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, Fadda F, Gessa GL. Gamma-hydroxybutyric acid for treatment of alcohol-withdrawal syndrome. The Lancet 1989; ii:787–789.
   Google Scholar
• DiBello MG, Gambassi F, Mugnai L, Masini E, Mannaioni PF. Gamma-hydroxybutyric acid induced suppression and prevention of alcohol-withdrawal syndrome and relief of craving in alcohol dependent patients. Alcologia 1995; 7:91–116.
   Google Scholar
• Addolorato G, Balducci G, Capestro G, Attilia ML, Taggi G, Gasbarrini G, Ceccanti M. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol-withdrawal syndrome: A randomized comparative study versus benzodiazepine. Alcoholism Clin Exp Res 1999; 23:1596–1604.
   PubMed Web of Science ®Google Scholar
• Nimmerrichter AA, Walter H, Gutierrez-Lobos KE, Lesch OM. Double-blind controlled trial of γ-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol Alcohol 2002; 37:67–73.
   PubMed Web of Science ®Google Scholar
• Korninger C, Roller RE, Lesch OM. Gamma-hydroxybutyric acid in the treatment of alcohol withdrawal syndrome in patients admitted to hospital. Acta Med Austriaca 2003; 3:83–86.
   Google Scholar
• Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: A double-blind chloromethiazole (a thiamine derivative) study. Alcohol Clin Exp Res 1992; 16:673–676.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Castelli E, Stefanini GF, Casella G, Caputo F, Marsigli L, Bernardi M, Gasbarrini G. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. Alcohol Alcohol 1996; 31:341–345.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Cibin M, Caprista E, Beghe F, Gessa GL, Stefanini GF, Gasbarrini G. Maintaining abstinence from alcohol with γ-hydroxybutyric acid. The Lancet 1998; 351:38.
   PubMed Web of Science ®Google Scholar
• Agabio R, Colombo G, Loche A, Lobina C, Pani ML, Reali R, Gessa GL. γ-hydroxybutyric acid reducing effect on ethanol intake: Evidence in favour of a substitution mechanism. Alcohol Alcohol 1998; 33:465–474.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Caputo F, Capristo E, Stefanini GF, Gasbarrini G. Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction. Alcohol 2000; 20:217–222.
   PubMed Web of Science ®Google Scholar
• Maremmani I, Lamanna F, Tagliamonte A. Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics. J Psychoactive Drugs 2001; 33:135–142.
   PubMed Web of Science ®Google Scholar
• Gessa GL, Agabio R, Carai MA, Lobina C, Pani M, Reali R, Colombo G. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. Alcohol 2002; 20:271–276.
   Web of Science ®Google Scholar
• Addolorato G, Caputo F, Stefanini GF, Gasbarrini G. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: Possibile craving development for the drug. Addiction 1997; 92:1041–1042.
   Web of Science ®Google Scholar
• Goodwin AK, Froestl W, Weerts EM. Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioural effects of GHB in baboons. Psychopharmacology 2005; 180:342–351.
   PubMed Web of Science ®Google Scholar
• Maitre M, Humbert JP, Kemmel V, Aunis D, Andriamampandry C. A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse. Med Sci 2005; 21:284–289.
   Google Scholar
• Adinoff B, Risher-Flowers D, De Jong J, Ravitz B, Bone GH, Nutt DJ, Roehrich L, Martin PR, Linnoila M. Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men. Am J Psychiatry 1991; 148:1023–1025.
   PubMed Web of Science ®Google Scholar
• Gallant DM, Pena JM. Plasma cortisol concentrations during ethanol withdrawal. Alcohol Clin Exp Res 1992; 16:139–140.
   Web of Science ®Google Scholar
• Heinz A, Rommelspacher H, Graf KJ, Kurten I, Otto M, Baumgartner A. Hypothalamic-pituitary-gonadal axis, prolactin, and cortisol in alcoholics during withdrawal and after three weeks of abstinence: Comparison with healthy control subjects. Psychiatry Res 1995; 56:81–95.
   PubMed Web of Science ®Google Scholar
• Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: Interaction with endogenous opioid peptides. Clin Endocrinol 1995; 43:283–290.
   PubMed Web of Science ®Google Scholar
• Adinoff B, Iranmanesh A, Veldhuis J, Fisher L. Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World 1998; 22:67–72.
   PubMedGoogle Scholar
• Mukai M, Uchimura N, Hirano T, Ohshima H, Nakamura J. Circadian rhythms of hormone concentrations in alcohol withdrawal. Psychiatry Clin Neurosci 1998; 52:238–240.
   PubMed Web of Science ®Google Scholar
• Keedwell PA, Poon L, Papadopoulos AS, Marshall EJ, Checkley SA. Salivary cortisol measurements during a medically assisted alcohol withdrawal. Addict Biol 2001; 6:247–256.
   PubMed Web of Science ®Google Scholar
• Zimmermann U, Hundt W, Spring K, Grabner A, Holsboer F. Hypothalamic-pituitary-adrenal system adaptation to detoxification in alcohol-dependent patients is affected by family history of alcoholism. Biol Psychiatry 2003; 53:75–84.
   PubMed Web of Science ®Google Scholar
• Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S. Suppression of the HPA axis stress-response: Implications for relapse. Alcohol Clin Exp Res 2005, 29:1351–1355.
   PubMed Web of Science ®Google Scholar
• Stuppaeck CH, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Whitworth AB, Fleischhacker WW. Assessment of the alcohol withdrawal syndrome-validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A). Addiction 1994; 89:1287–1292.
   PubMed Web of Science ®Google Scholar
• Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addiction 1989; 84:1353–1357.
   PubMedGoogle Scholar
• Wand GS, Dobs AS. Alterations in the hypothalamic-pituitary-adrenal axis is actively drinking alcoholic. J Clin Endocrinology Metab 1991; 72:1290–1295.
   PubMed Web of Science ®Google Scholar
• Lovallo WR, Dickensheets SL, Myers DA, Thomas TL, Nixon SJ. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin Exp Res 2000; 24:651–658.
   PubMed Web of Science ®Google Scholar
• Junghanns K, Backhauss J, Tietz U, Lange W, Bernzen J, Wetterling T, Rink L, Driessen M. Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol 2003; 38:189–193.
   PubMed Web of Science ®Google Scholar
• Junghanns K, Tietz U, Dibbelt L, Kuether M, Jurth R, Ehrenthal D, Blank S, Backhaus J. Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol 2005; 40:80–85.
   PubMed Web of Science ®Google Scholar
• Errico AL, King AC, Lovallo WR, Parsons OA. Cortisol dysregulation and cognitive impairment in abstinent male alcoholics. Alcohol Clin Exp Res 2002; 26:1198–1204.
   PubMed Web of Science ®Google Scholar
• Heinz A, Jones DW, Bissette G, Hommer D, Ragan P, Knable M, Wellek S, Linnoila M, Weinberger DR. Relationship between cortisol and serotonin metabolities and transporters in alcoholism. Pharmacopsychiatry 2002; 35:127–134.
   PubMed Web of Science ®Google Scholar
• Kutscher S, Heise DJ, Banger M, Saller B, Michel MC, Gastpar M, Schedlowski M, Exton M. Concomitant endocrine and immune alterations during alcohol intoxication and acute withdrawal in alcohol-dependent subjects. Neuropsychobiology 2002; 45:144–149.
   PubMed Web of Science ®Google Scholar